Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Now, a study on the utility of hydroxychloroquine as prophylaxis against COVID-19, has been released in the latest issue of Annals of Internal Medicine.

Hydroxychloroquine found ineffective as post-exposure SARS-CoV-2 prophylaxis

Over 69.41 million people around the world have been infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and, of these, over 1.49 million people have lost their lives. The spread of the virus from person to person is rapid and has brought the economies of major nations to their knees due to public health measures preventing human movement over the last few months.

Hydroxychloroquine prophylaxis to prevent COVID-19 had gathered interest during the initial phases of the pandemic early this year (2020). Studies quickly proved it to be less than effective in preventing the infection or reducing viral load or severe disease in infected persons.

Now, a study on the utility of hydroxychloroquine as prophylaxis against COVID-19, has been released in the latest issue of Annals of Internal Medicine.